Skip to main content
Top
Published in: Cancer Imaging 1/2015

Open Access 01-12-2015 | Research article

Changes of lung tumour volume on CT - prediction of the reliability of assessments

Authors: Hubert Beaumont, Simon Souchet, Jean Marc Labatte, Antoine Iannessi, Anthony William Tolcher

Published in: Cancer Imaging | Issue 1/2015

Login to get access

Abstract

Background

For oncological evaluations, quantitative radiology gives clinicians significant insight into patients’ response to therapy. In regard to the Response Evaluation Criteria in Solid Tumours (RECIST), the classification of disease evolution partly consists in applying thresholds to the measurement of the relative change of tumour. In the case of tumour volumetry, response thresholds have not yet been established. This study proposes and validates a model for calculating thresholds for the detection of minimal tumour change when using the volume of pulmonary lesions on CT as imaging biomarker.

Methods

Our work is based on the reliability analysis of tumour volume measurements documented by the Quantitative Imaging Biomarker Alliance. Statistics of measurements were entered into a multi-parametric mathematical model of the relative changes derived from the Geary-Hinkley transformation. The consistency of the model was tested by comparing modelled thresholds against Monte Carlo simulations of tumour volume measurements with additive random error. The model has been validated by repeating measurements on real patient follow ups.

Results

For unchanged tumour volume, relying on a normal distribution of error, the agreement between model and simulations featured a type I error of 5.25 %. Thus, we established that a threshold of 35 % of volume reduction corresponds to a partial response (PR) and a 55 % volume increase corresponds to progressive disease (PD). Changes between −35 and +55 % are categorized as stable disease (SD). Tested on real clinical data, 97.1 % [95.7; 98.0] of assessments fall into the range of variability predicted by our model of confidence interval.

Conclusions

Our study indicates that the Geary Hinkley model, using published statistics, is appropriate to predict response thresholds for the volume of pulmonary lesions on CT.
Appendix
Available only for authorised users
Literature
2.
go back to reference Cedrés S, Quispe I, Martínez P, Longo M, Rodríguez E, Serrano C, et al. Computed tomography (CT) predicts accurately the pathologic tumour size in stage I non-small-cell lung cancer (NSCLC). Clin Transl Oncol. 2010;12:829–35.CrossRefPubMed Cedrés S, Quispe I, Martínez P, Longo M, Rodríguez E, Serrano C, et al. Computed tomography (CT) predicts accurately the pathologic tumour size in stage I non-small-cell lung cancer (NSCLC). Clin Transl Oncol. 2010;12:829–35.CrossRefPubMed
3.
go back to reference Takumi K, Fukukura Y, Higashi M, Ideue J, Umanodan T, Hakamada H, et al. Pancreatic neuroendocrine tumors: Correlation between the contrast-enhanced computed tomography features and the pathological tumor grade. Eur J Radiol. 2015;84:1436–43.CrossRefPubMed Takumi K, Fukukura Y, Higashi M, Ideue J, Umanodan T, Hakamada H, et al. Pancreatic neuroendocrine tumors: Correlation between the contrast-enhanced computed tomography features and the pathological tumor grade. Eur J Radiol. 2015;84:1436–43.CrossRefPubMed
4.
go back to reference Retraction. J Clin Oncol. 2012;30:4179–4179. Retraction. J Clin Oncol. 2012;30:4179–4179.
5.
go back to reference Karp DD, Paz-Ares LG, Novello S, Haluska P, Garland L, Cardenal F, et al. Phase II study of the anti-insulin-like growth factor type 1 receptor antibody CP-751,871 in combination with paclitaxel and carboplatin in previously untreated, locally advanced, or metastatic non-small-cell lung cancer. J Clin Oncol. 2009;27:2516–22.CrossRefPubMed Karp DD, Paz-Ares LG, Novello S, Haluska P, Garland L, Cardenal F, et al. Phase II study of the anti-insulin-like growth factor type 1 receptor antibody CP-751,871 in combination with paclitaxel and carboplatin in previously untreated, locally advanced, or metastatic non-small-cell lung cancer. J Clin Oncol. 2009;27:2516–22.CrossRefPubMed
6.
go back to reference Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45:228–47.CrossRefPubMed Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45:228–47.CrossRefPubMed
7.
go back to reference Sharma MR, Maitland ML, Ratain MJ, Fojo AT, Noonan A. RECIST: No longer the sharpest tool in the oncology clinical trials toolbox - Point/Counterpoint. Cancer Res. 2012;72:5145–50.CrossRefPubMed Sharma MR, Maitland ML, Ratain MJ, Fojo AT, Noonan A. RECIST: No longer the sharpest tool in the oncology clinical trials toolbox - Point/Counterpoint. Cancer Res. 2012;72:5145–50.CrossRefPubMed
8.
go back to reference Oxnard GR, Zhao B, Sima CS, Ginsberg MS, James LP, Lefkowitz RA, et al. Variability of lung tumor measurements on repeat computed tomography scans taken within 15 min. J Clin Oncol. 2011;29:3114–9.PubMedCentralCrossRefPubMed Oxnard GR, Zhao B, Sima CS, Ginsberg MS, James LP, Lefkowitz RA, et al. Variability of lung tumor measurements on repeat computed tomography scans taken within 15 min. J Clin Oncol. 2011;29:3114–9.PubMedCentralCrossRefPubMed
9.
go back to reference Revel M-P, Lefort C, Bissery A, Bienvenu M, Aycard L, Chatellier G, et al. Pulmonary nodules: preliminary experience with three-dimensional evaluation. Radiology. 2004;231:459–66.CrossRefPubMed Revel M-P, Lefort C, Bissery A, Bienvenu M, Aycard L, Chatellier G, et al. Pulmonary nodules: preliminary experience with three-dimensional evaluation. Radiology. 2004;231:459–66.CrossRefPubMed
10.
12.
go back to reference van Klaveren RJ, Oudkerk M, Prokop M, Scholten ET, Nackaerts K, Vernhout R, et al. Management of lung nodules detected by volume CT scanning. N Engl J Med. 2009;361:2221–9.CrossRefPubMed van Klaveren RJ, Oudkerk M, Prokop M, Scholten ET, Nackaerts K, Vernhout R, et al. Management of lung nodules detected by volume CT scanning. N Engl J Med. 2009;361:2221–9.CrossRefPubMed
13.
go back to reference Mozley PD, Schwartz LH, Bendtsen C, Zhao B, Petrick N, Buckler AJ. Change in lung tumor volume as a biomarker of treatment response: a critical review of the evidence. Ann Oncol. 2010;21:1751–5.CrossRefPubMed Mozley PD, Schwartz LH, Bendtsen C, Zhao B, Petrick N, Buckler AJ. Change in lung tumor volume as a biomarker of treatment response: a critical review of the evidence. Ann Oncol. 2010;21:1751–5.CrossRefPubMed
14.
go back to reference Mozley PD, Bendtsen C, Zhao B, Schwartz LH, Thorn M, Rong Y, et al. Measurement of tumor volumes improves RECIST-based response assessments in advanced lung cancer. Transl Oncol. 2012;5:19–25.PubMedCentralCrossRefPubMed Mozley PD, Bendtsen C, Zhao B, Schwartz LH, Thorn M, Rong Y, et al. Measurement of tumor volumes improves RECIST-based response assessments in advanced lung cancer. Transl Oncol. 2012;5:19–25.PubMedCentralCrossRefPubMed
15.
go back to reference Ford R, Schwartz L, Dancey J, Dodd LE, Eisenhauer EA, Gwyther S, et al. Lessons learned from independent central review. Eur J Cancer. 2009;45:268–74.CrossRefPubMed Ford R, Schwartz L, Dancey J, Dodd LE, Eisenhauer EA, Gwyther S, et al. Lessons learned from independent central review. Eur J Cancer. 2009;45:268–74.CrossRefPubMed
16.
go back to reference Buckler AJ, Bresolin L, Dunnick NR, Sullivan DC. A collaborative enterprise for multi-stakeholder participation in the advancement of quantitative imaging. Radiology. 2011;258:906–14.CrossRefPubMed Buckler AJ, Bresolin L, Dunnick NR, Sullivan DC. A collaborative enterprise for multi-stakeholder participation in the advancement of quantitative imaging. Radiology. 2011;258:906–14.CrossRefPubMed
18.
go back to reference Radiology ES of. ESR statement on the stepwise development of imaging biomarkers. Insights Imaging. 2013;4:147–52.CrossRef Radiology ES of. ESR statement on the stepwise development of imaging biomarkers. Insights Imaging. 2013;4:147–52.CrossRef
19.
go back to reference Nishino M, Guo M, Jackman DM, DiPiro PJ, Yap JT, Ho TK, et al. CT tumor volume measurement in advanced non-small-cell lung cancer: Performance characteristics of an emerging clinical tool. Acad Radiol. 2011;18:54–62.PubMedCentralCrossRefPubMed Nishino M, Guo M, Jackman DM, DiPiro PJ, Yap JT, Ho TK, et al. CT tumor volume measurement in advanced non-small-cell lung cancer: Performance characteristics of an emerging clinical tool. Acad Radiol. 2011;18:54–62.PubMedCentralCrossRefPubMed
20.
go back to reference Hinkley DV. On the ratio of two correlated normal random variables. Biometrika. 1969;56:635–9.CrossRef Hinkley DV. On the ratio of two correlated normal random variables. Biometrika. 1969;56:635–9.CrossRef
21.
go back to reference Hayya J, Armstrong D, Gressis N. A note on the ratio of two normally distributed variables. Manage Sci. 1975;21:1338–41.CrossRef Hayya J, Armstrong D, Gressis N. A note on the ratio of two normally distributed variables. Manage Sci. 1975;21:1338–41.CrossRef
22.
go back to reference Raftery AE, Schweder T. Inference about the ratio of two parameters, with application to whale censusing. Am Stat. 1993;47:259–64. Raftery AE, Schweder T. Inference about the ratio of two parameters, with application to whale censusing. Am Stat. 1993;47:259–64.
23.
go back to reference Team RDC. R: A Language and Environment for Statistical Computing. Vienna: R Foundation for Statistical Computing [R Foundation for Statistical Computing]; 2011. p. 409. Team RDC. R: A Language and Environment for Statistical Computing. Vienna: R Foundation for Statistical Computing [R Foundation for Statistical Computing]; 2011. p. 409.
24.
go back to reference Goodman LR, Gulsun M, Washington L, Nagy PG, Piacsek KL. Inherent variability of CT lung nodule measurements in vivo using semiautomated volumetric measurements. AJR Am J Roentgenol. 2006;186:989–94.CrossRefPubMed Goodman LR, Gulsun M, Washington L, Nagy PG, Piacsek KL. Inherent variability of CT lung nodule measurements in vivo using semiautomated volumetric measurements. AJR Am J Roentgenol. 2006;186:989–94.CrossRefPubMed
25.
go back to reference Zhao B, Tan Y, Bell D, Marley S. Intra-and inter-reader variability in uni-dimensional, bi-dimensional, and volumetric measurements of solid tumors on CT scans reconstructed at different slice intervals. Eur J Radiol. 2013;82:1–22.CrossRef Zhao B, Tan Y, Bell D, Marley S. Intra-and inter-reader variability in uni-dimensional, bi-dimensional, and volumetric measurements of solid tumors on CT scans reconstructed at different slice intervals. Eur J Radiol. 2013;82:1–22.CrossRef
26.
go back to reference Wang Y, van Klaveren RJ, van der Zaag-Loonen HJ, de Bock GH, Gietema HA, Xu DM, et al. Effect of nodule characteristics on variability of semiautomated volume measurements in pulmonary nodules detected in a lung cancer screening program. Radiology. 2008;248:625–31.CrossRefPubMed Wang Y, van Klaveren RJ, van der Zaag-Loonen HJ, de Bock GH, Gietema HA, Xu DM, et al. Effect of nodule characteristics on variability of semiautomated volume measurements in pulmonary nodules detected in a lung cancer screening program. Radiology. 2008;248:625–31.CrossRefPubMed
27.
go back to reference Zhao B, James LP, Moskowitz CS, Guo P, Ginsberg MS, Lefkowitz RA, et al. Evaluating variability in tumor measurements from same-day repeat CT scans of patients with non-small cell lung cancer. Radiology. 2009;252:263–72.PubMedCentralCrossRefPubMed Zhao B, James LP, Moskowitz CS, Guo P, Ginsberg MS, Lefkowitz RA, et al. Evaluating variability in tumor measurements from same-day repeat CT scans of patients with non-small cell lung cancer. Radiology. 2009;252:263–72.PubMedCentralCrossRefPubMed
28.
go back to reference Gietema HA, Wang Y, Xu D, van Klaveren RJ, de Koning H, Scholten E, et al. Pulmonary nodules detected at lung cancer screening: interobserver variability of semiautomated volume measurements. Radiology. 2006;241:251–7.CrossRefPubMed Gietema HA, Wang Y, Xu D, van Klaveren RJ, de Koning H, Scholten E, et al. Pulmonary nodules detected at lung cancer screening: interobserver variability of semiautomated volume measurements. Radiology. 2006;241:251–7.CrossRefPubMed
29.
go back to reference Zhao B, Oxnard GR, Moskowitz CS, Kris MG, Pao W, Guo P, et al. A pilot study of volume measurement as a method of tumor response evaluation to aid biomarker development. Clin Cancer Res. 2010;16:4647–53.PubMedCentralCrossRefPubMed Zhao B, Oxnard GR, Moskowitz CS, Kris MG, Pao W, Guo P, et al. A pilot study of volume measurement as a method of tumor response evaluation to aid biomarker development. Clin Cancer Res. 2010;16:4647–53.PubMedCentralCrossRefPubMed
31.
go back to reference Hein PA, Romano VC, Rogalla P, Klessen C, Lembcke A, Dicken V, et al. Linear and volume measurements of pulmonary nodules at different CT dose levels - intrascan and interscan analysis. Röfo. 2009;181:24–31.PubMed Hein PA, Romano VC, Rogalla P, Klessen C, Lembcke A, Dicken V, et al. Linear and volume measurements of pulmonary nodules at different CT dose levels - intrascan and interscan analysis. Röfo. 2009;181:24–31.PubMed
Metadata
Title
Changes of lung tumour volume on CT - prediction of the reliability of assessments
Authors
Hubert Beaumont
Simon Souchet
Jean Marc Labatte
Antoine Iannessi
Anthony William Tolcher
Publication date
01-12-2015
Publisher
BioMed Central
Published in
Cancer Imaging / Issue 1/2015
Electronic ISSN: 1470-7330
DOI
https://doi.org/10.1186/s40644-015-0052-2

Other articles of this Issue 1/2015

Cancer Imaging 1/2015 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine